AKT1 and neoplasm: inhibits tumor angiogenesis in vitro and in vivo by suppressing HIF-1α/VEGF through the Akt/mTOR/phospho-p70 S6 kinase (p70S6K) signaling pathway, thereby exerting cancer-suppressive effects (97).